Announcement PDF ASX ANNOUNCEMENT JOBKEEPER PAYMENTS NOTICE MELBOURNE (AUSTRALIA) 1 November 2021: Invion Limited (ASX: IVX) (“Invion” or the “Company”) provides the appended notice in accordance with section 323DB(1) of the Corporations Act 2001 (Cth). The release of this announcement was authorised by the Company Secretary. ____________________________________________ Investor and Media enquiries: Thian Chew (Chairman & CEO) T: +61 3 8618 6843 E: investor@inviongroup.com Brendon Lau (Investor & Media Relations) M: +61 409 341 613 E: brendon.lau@inviongroup.com About Invion Invion is a life-science company that is leading the global research and development of PhotosoftTM technology for the treatment of a range of cancers, atherosclerosis and infectious diseases. Invion holds the exclusive Australia and New Zealand license rights to the PhotosoftTM technology for all cancer indications and Asia Pacific (excluding Greater China) for atherosclerosis and infectious diseases. Research and clinical cancer trials are funded by the technology licensor, RMW Cho Group Limited, via an R&D services agreement with the Company. Invion is listed on the ASX (ASX: IVX). This announcement was approved for release by Thian Chew, Chairman of the Board. About Photodynamic Therapy (PDT) Invion is developing PhotosoftTM technology as an improved next generation Photodynamic Therapy. PDT uses non-toxic photosensitisers and visible light in combination with oxygen to produce cytotoxic-reactive oxygen that kills malignant cells, shuts down tumours and stimulates the immune system. A potential alternative to surgery, and in contrast to radiotherapy and chemotherapy, which are mostly immunosuppressive, PDT causes acute inflammation, expression of heat-shock proteins, and invasion and infiltration of a tumour by leukocytes. Invion Limited ABN 76 094 730 417 100 Albert Road, South Melbourne, VIC 3205 P: +61 3 9692 7222 W: www.inviongroup.com Jobkeeper Payments Notification A notice for release to the market under subsection 323DB(1) of the Corporations Act 2001jobkeeper payments disclosure by listed entity. Date of this notice 10/27/2021 Listed entity details Australian Business Number (ABN) ASX/NSX/SSX issuer code 76094730417 IVX Name of the listed entity Invion Limited Jobkeeper payments This notice relates to the financial years ended 06/30/2020 (FY 1) and 06/30/2021 (FY 2). The number of individuals for whom the listed entity or a subsidiary of the listed entity received a jobkeeper payment for a jobkeeper fortnight that ended in the financial year(within the meaning of the Coronavirus Economic Response Package (Payments and Benefits) Rules 2020). FY 1: 3 FY 2: 3 The sum of all jobkeeper payments the listed entity, and each subsidiary of the listed entity, received in a jobkeeper fortnight that ended in the financial year. FY 1: $18,000 FY 2: $39,300 Has the listed entity or a subsidiary of the listed entity, made one or more voluntary payments (whether or not in the financial year) to the Commonwealth by way of a repayment of jobkeeper payments received by the listed entity or a subsidiary of the listed in the financial year? NO If the listed entity or a subsidiary of the listed entity has made such a voluntary payment or payments –the sum of those payments: FY 1:$0 FY 2:$0